This facility will be constructed on a site adjacent to the companies existing plant and will focus on the production of vaccines and biologics. It is scheduled to commence manufacturing operations in 2022. The build phase will also see approximately 700 tradespeople employed on site. The planning application details the construction of a new production building consisting of two production suites – a syringe filling and inspection suite and a vial filling suite – supporting clean utilities as well as an expansion of warehouse at the site.

WiiGroup’s scope is to manage the End to End project timeline along with Schedule Quality to ensure systems, facilities and equipment understand their independent interfaces and meet the timeline requirements.

Sector: End to End

Contract: BioPharma

Completion Year: 2022

Location: Ireland

Services

• Managing Contractor Schedules
• Schedule Quality Management
• Progress Evaluation
• Reporting